Literature DB >> 8110453

Sulphatide antigen in islets of Langerhans and in diabetic glomeruli, and anti-sulphatide antibodies in type 1 diabetes mellitus.

K Buschard1, K Josefsen, T Horn, S Larsen, P Fredman.   

Abstract

Clinical coincidence between diabetes and neurological disorders, and sharing of antigen determinants between islets of Langerhans and neural tissue, has been suggested. Sulphatide is a neural epitope which can be visualized with a monoclonal antibody Sulph I. Different tissues were examined by immunohistological methods. Sulphatide and anti-sulphatide antibodies were determined by thin-layer chromatographic techniques. IgG was isolated using protein A columns. A specific staining by Sulph I was found of rat islets, assigned to the secretory granules of both alpha and beta cells. No labelling of the exocrine tissue or other body tissues was seen, except for nerve and kidney structures. The latter showed staining of the distal tubules and, in addition, but only in the diabetic kidney, of glomeruli located in the subendothelial area in the capillary loops and the mesangial space. Sera from 38% of 40 spontaneously diabetic BB rats displayed anti-sulphatide antibodies, mainly IgG, whereas all 30 control Lewis rats were negative. Most recently we have demonstrated anti-sulphatide antibodies in 88% of 57 patients with newly diagnosed Type 1 diabetes (titres of > 1:400); all 135 healthy control persons were negative. The sulphatide antibody reactivity was present in the IgG fractions of the patients' sera. Thus, sulphatide is demonstrated in islets of Langerhans and in kidney related to the diabetic lesion, and, furthermore, anti-sulphatide antibodies exist in Type 1 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8110453     DOI: 10.1111/j.1699-0463.1993.tb00208.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

1.  Design of a covalently bonded glycosphingolipid microarray.

Authors:  Emma Arigi; Ola Blixt; Karsten Buschard; Henrik Clausen; Steven B Levery
Journal:  Glycoconj J       Date:  2011-11-22       Impact factor: 2.916

2.  Presence of sulphatide (3'-sulphogalactosylceramide) in pericytes in the choroid layer of the eye: sharing of this glycolipid autoantigen with islets of Langerhans.

Authors:  K Buschard; T Horn; K Aaen; K Josefsen; H Persson; P Fredman
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

3.  Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model.

Authors:  M Kyogashima; J Onaya; A Hara; T Taketomi
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

4.  Sulphatide in islets of Langerhans and in organs affected in diabetic late complications: a study in human and animal tissue.

Authors:  K Buschard; K Josefsen; S V Hansen; T Horn; M O Marshall; H Persson; J E Månsson; P Fredman
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

5.  Sulfatide is associated with insulin granules and located to microdomains of a cultured beta cell line.

Authors:  Maria Blomqvist; Thomas Osterbye; Jan-Eric Månsson; Thomas Horn; Karsten Buschard; Pam Fredman
Journal:  Glycoconj J       Date:  2002-07       Impact factor: 2.916

6.  Uptake of the glycosphingolipid sulfatide in the gastrointestinal tract and pancreas in vivo and in isolated islets of Langerhans.

Authors:  Maria Blomqvist; Thomas Osterbye; Jan-Eric Månsson; Karsten Buschard; Pam Fredman
Journal:  Lipids Health Dis       Date:  2006-10-17       Impact factor: 3.876

Review 7.  Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.

Authors:  Shelby Loraine Hatton; Manoj Kumar Pandey
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.